Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George Coukos

Showing results (141-150 of 355) with videos related to

Pageof 36
Sort By:
Molecular & Cellular Proteomics : MCP|April 12, 2021
Sensitive Immunopeptidomics by Leveraging Available Large-Scale Multi-HLA Spectral Libraries, Data-Independent Acquisition, and MS/MS PredictionHuiSong Pak, Justine Michaux, Florian Huber, et al.
Cancer Research|September 19, 2007
Relationship between B7-H4, regulatory T cells, and patient outcome in human ovarian carcinomaIlona Kryczek, Shuang Wei, Gefeng Zhu, et al.
Journal of Proteome Research|October 29, 2011
A xenograft mouse model coupled with in-depth plasma proteome analysis facilitates identification of novel serum biomarkers for human ovarian cancerHsin-Yao Tang, Lynn A Beer, Tony Chang-Wong, et al.
Gynecologic Oncology|December 5, 2009
The emergence of immunomodulation: combinatorial immunochemotherapy opportunities for the next decadeLana E Kandalaft, Nathan Singh, John B Liao, et al.
International Journal of Molecular Sciences|September 9, 2020
Mineral and Amino Acid Profiling of Different Hematopoietic Populations from the Mouse Bone MarrowMukul Girotra, Caroline Monnard, Tobias Konz, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 16, 2018
The Length Distribution and Multiple Specificity of Naturally Presented HLA-I LigandsDavid Gfeller, Philippe Guillaume, Justine Michaux, et al.
The American Journal of Pathology|December 6, 2002
Generation of a syngeneic mouse model to study the effects of vascular endothelial growth factor in ovarian carcinomaLin Zhang, Nuo Yang, Jose-Ramon Conejo Garcia, et al.
Oncotarget|April 15, 2017
The ovarian cancer oncobiomeSagarika Banerjee, Tian Tian, Zhi Wei, et al.
Cancer Immunology Research|November 1, 2014
T cells bearing a chimeric antigen receptor against prostate-specific membrane antigen mediate vascular disruption and result in tumor regressionStephen P Santoro, Soorin Kim, Gregory T Motz, et al.
Gynecologic Oncology|December 21, 2010
Clinical predictors of bevacizumab-associated gastrointestinal perforationJanos L Tanyi, Georgia McCann, Andrea R Hagemann, et al.
Pageof 36

Showing results (141-150 of 355) with videos related to

Sort By:
Pageof 36
Molecular & Cellular Proteomics : MCP|April 12, 2021
Sensitive Immunopeptidomics by Leveraging Available Large-Scale Multi-HLA Spectral Libraries, Data-Independent Acquisition, and MS/MS PredictionHuiSong Pak, Justine Michaux, Florian Huber, et al.
Cancer Research|September 19, 2007
Relationship between B7-H4, regulatory T cells, and patient outcome in human ovarian carcinomaIlona Kryczek, Shuang Wei, Gefeng Zhu, et al.
Journal of Proteome Research|October 29, 2011
A xenograft mouse model coupled with in-depth plasma proteome analysis facilitates identification of novel serum biomarkers for human ovarian cancerHsin-Yao Tang, Lynn A Beer, Tony Chang-Wong, et al.
Gynecologic Oncology|December 5, 2009
The emergence of immunomodulation: combinatorial immunochemotherapy opportunities for the next decadeLana E Kandalaft, Nathan Singh, John B Liao, et al.
International Journal of Molecular Sciences|September 9, 2020
Mineral and Amino Acid Profiling of Different Hematopoietic Populations from the Mouse Bone MarrowMukul Girotra, Caroline Monnard, Tobias Konz, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 16, 2018
The Length Distribution and Multiple Specificity of Naturally Presented HLA-I LigandsDavid Gfeller, Philippe Guillaume, Justine Michaux, et al.
The American Journal of Pathology|December 6, 2002
Generation of a syngeneic mouse model to study the effects of vascular endothelial growth factor in ovarian carcinomaLin Zhang, Nuo Yang, Jose-Ramon Conejo Garcia, et al.
Oncotarget|April 15, 2017
The ovarian cancer oncobiomeSagarika Banerjee, Tian Tian, Zhi Wei, et al.
Cancer Immunology Research|November 1, 2014
T cells bearing a chimeric antigen receptor against prostate-specific membrane antigen mediate vascular disruption and result in tumor regressionStephen P Santoro, Soorin Kim, Gregory T Motz, et al.
Gynecologic Oncology|December 21, 2010
Clinical predictors of bevacizumab-associated gastrointestinal perforationJanos L Tanyi, Georgia McCann, Andrea R Hagemann, et al.
Pageof 36